Back |

MATTAWAN, July 14, 2006: As a global leader in preclinical pharmaceutical, biopharmaceutical and medical device research and development, MPI Research will conduct training on Good Laboratory Practices (GLP) compliance at the esteemed China Life Sciences Summit, being held in Beijing, PRC on July 27-28, 2006. Jointly sponsored by the China Center for Pharmaceutical International Exchange (CCPIE), the China State Food & Drug Administration (SFDA), the China Pharmaceutical Enterprises Management Association, and the Beijing Pharmaceutical Group Companies (BPGC), this prestigious meeting provides a platform for knowledge sharing by biotech and pharmaceutical thought leaders as well as networking opportunities among a body of international industry decision-makers.

“With one-fourth of the world’s population, China is an important force in shaping the global pharmaceutical and medical device market,” says MPI Research’s President and COO, William Harrison. “Our domestic as well as our international Sponsors value the GLP standards at MPI Research, and we are pleased to lead an educational initiative to set the bar in this arena. We look forward to having high-level discussions about GLP’s and other relevant topics with key players in China’s growing biopharmaceutical industry.”

MPI Research focuses on quality and timeliness in providing comprehensive preclinical research, from early proof of concept testing to regulatory submissions. Because of increased demands for its scientific expertise and broad scope of services, MPI Research is enlarging its facilities on its 130-acre site while continuing to meet the needs of its Sponsors. Yet, the service commitment goes beyond the state-of-the-art facilities and innovative processes. The company values results, and its team of 1,000+ employees efficiently create and implement standardized and custom GLP research programs within the broad areas of toxicology, pathology, efficacy, medical devices and safety pharmacology. Known for its proactive problem-solving capabilities, it’s no accident that MPI Research has a reputation of being the best in its field.

Visit us at the MPI Research booth at this important meeting (http://www.Chinalifescience.org) or at www.mpiresearch.com, to learn how we can assist you in bringing safer, better pharmaceuticals, biopharmaceuticals, medical devices and healthcare products to the world.

Home | News